Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Buyers’ clubs: the first step toward universal UK access to Orkambi?

In response to failing negotiations between the UK’s National Health Service and Vertex over the CF drug Orkambi, parents of children with CF have created a buyers’ club to get access to an Argentinian generic version of the drug. Can a buyers’ club triumph where government-industry negotiations have failed?


Go Top